Accelerating clinical drug development for children with tuberculosis.


Despite urgent need, the development, approval and availability of child-friendly anti-tuberculosis drugs lag significantly behind that of adults, with children having been ignored in anti-tuberculosis drug development research. This paper outlines possible strategies for accelerating and better integrating the development of drugs and regimens for… (More)
DOI: 10.5588/ijtld.15.0616


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.

Slides referencing similar topics